<DOC>
	<DOCNO>NCT01669200</DOCNO>
	<brief_summary>The primary aim study ass whether daily dose medium chain triglyceride subject mild cognitive impairment ( MCI ) improve cognitive performance .</brief_summary>
	<brief_title>Effect Medium Chain Triglyceride Oil Supplementation Mild Cognitive Impairment</brief_title>
	<detailed_description>Twenty eligible subject enrol study consist baseline visit follow six post-baseline visit . The control placebo group comprise ten subject randomly assign group . The assessment baseline include concomitant medication , vital sign , height , weight . In addition , subject complete medical history questionnaire , receive group instruction incorporation study product diet registered dietitian . Study product dispense visit excess requirement , re-issued every visit measurement remain product subject instruct bring every visit . The post-baseline study visit include body weight vital sign measurement , concomitant medication , dispensation study product , group instruction register dietitian , assessment adverse event . Between study visit subject receive telephone call study coordinator encourage compliance diet , ask adverse event . The study visit conclude week 24 . The psychological test conduct clinician screen repeat cognitive test visit .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Are male female diagnosis Mild Cognitive Impairment 2 . Are 50 year age old 1 . Been medication Mild Cognitive Impairment le 90 day 2 . Major depression 3 . Uncontrolled hypothyroidism 4 . Known B12 deficiency 5 . Hepatic ( liver ) disease insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>